ArticleFrontiers in global women's health2026
Marginalized voices on HPV vaccination in India: exploring knowledge, attitudes, and acceptance.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cervical cancer remains a major cause of morbidity and mortality among women in India, particularly among marginalized communities who face heightened vulnerability to Human papillomavirus (HPV)-related disease. As India prepares for the national rollout of HPV vaccination for girls aged 9-14 years, understanding community-level knowledge, attitudes, and acceptability is essential to ensuring equitable uptake. This study explored perceptions of HPV vaccination among marginalized populations across three diverse Indian settings. Methods: A multi-site qualitative study was conducted between February and October 2023 in Delhi-NCR, Tripura, and Karnataka. Semi-structured interviews ( Results: Awareness of HPV vaccination was extremely low, with only 14 participants having heard of the vaccine, and only one male participant aware of it. While many participants expressed willingness to vaccinate themselves or their daughters, others held cautious or negative views rooted in concerns about side effects, fertility, moral beliefs, and confusion linked to the COVID-19 vaccination experience. Gendered decision-making norms shaped vaccine acceptance, with many women relying on husbands or senior family members for consent. Participants emphasized culturally grounded, community-based strategies for vaccine introduction, including locally tailored communication and engagement through trusted community actors. Discussion and conclusion: This multi-site qualitative study highlights the interplay of limited knowledge, gendered power dynamics, stigma, and trust in shaping HPV vaccine acceptability among marginalized populations in India. To enhance vaccine knowledge and acceptability, tailored community engagement, culturally responsive communication, and inclusive decision-making processes are essential. As India advances towards national HPV vaccine rollout, addressing these factors will be critical for achieving equitable coverage and supporting cervical cancer elimination goals.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.